Tender detail

Conclusion of non-exclusive rebate agreements for the active substance ustekinumab from 1 January 2027

Summary

GWQ ServicePlus AG is seeking non-exclusive medicine rebate agreements with pharmaceutical companies for medicines containing the active substance ustekinumab, supplied at the expense of statutory health insurers. The agreements are intended to apply from 1 January 2027 until any exclusive medicine rebate agreements take effect.

Reference number
3da9517f-fd27-40d2-8061-93f39161d624
Buyer
GWQ ServicePlus AG
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-08-10
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.